durvalumab as a consolidation therapy for locally advanced nsclc
Published 6 years ago • 121 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
1:01
impact of durvalumab as consolidation therapy in nsclc
-
3:07
the use of durvalumab in locally advanced nsclc
-
25:26
locally advanced nsclc: combination therapy with targeted and immunotherapy agents
-
6:23
case 1: consolidation therapy in locally advanced nsclc
-
4:15
safety profile of durvalumab in locally advanced nsclc
-
5:13
effectively managing treatment with durvalumab
-
3:22
locally advanced nsclc: durvalumab and the pacific trial
-
5:28
durvalumab consolidation in nsclc: the pacific trial
-
3:57
anti–pd-l1 therapy for locally advanced nsclc
-
1:18
a study of chemotherapy with durvalumab and tremelimumab in nsclc
-
3:53
[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital
-
2:52
examining recent pacific trial updates for durvalumab in locally advanced nsclc
-
8:20
durvalumab after crt in locally advanced nsclc
-
6:22
refining which patients benefit from consolidation durvalumab for stage iii unresectable nsclc
-
3:45
options for systemic therapy in locally advanced nsclc
-
6:50
implications for using durvalumab in stage 3 nsclc
-
1:38
practical considerations for durvalumab in stage 3 nsclc
-
4:44
is targeted therapy feasible as consolidation in locally advanced nsclc?
-
6:47
case 1: immunotherapy in locally advanced nsclc